Founder's components: STK3/4 (MST1/2), LATS1/2, SAV1, MOB1, NF2, YAP1, WWTR1/TAZ, TEAD1-4, FAT1-4. This is the one node of the ten that the founder's own page does NOT mark "In the recommender".
DRY status
DRY: none located. No dry-fast study measured MST1/2, LATS1/2, SAV1, MOB1, NF2, YAP1, TAZ, any TEAD or any FAT. Queries run: the four DRY queries under node 1, plus "fasting YAP TAZ Hippo signaling liver mouse nutrient deprivation", "caloric restriction Hippo LATS1 MST1 YAP adipose tissue signaling rodent", "fasting liver YAP Hippo pathway activation refeeding mouse hepatocyte starvation LATS". Empty for DRY.
Disconfirming, nulls and contradictions first
- No human study located measured any Hippo component under any fasting modality. [M, grade C]
- NEITHER animal study states the DIRECTION of the endogenous YAP or TAZ change during fasting. Li et al. 2023 report that fasting or refeeding "altered" YAP expression and its downstream target CCND1, and the retrieved abstract gives no direction and no numbers. Choi et al. 2024 report that YAP/TAZ activity is "associated with, and functionally required for" leptin regulation during fasting and refeeding, and the retrieved abstract gives no direction for the fasting change either. Two independent groups establish that YAP matters during the fasting-refeeding transition and neither retrieved record says which way it moves. A directional claim on this node is not available. [A1, grade C]
- Both studies establish requirement by manipulation, not by measurement of the fasting response. Li et al. used AAV-Yap(5SA) overexpression and Yap shRNA knockdown; Choi et al. used adipocyte Lats1/Lats2 deletion. What is demonstrated is that YAP is necessary, not that fasting regulates it in a stated direction. [A1, grade C]
- The two studies disagree on tissue and on what YAP does there. In liver, YAP overexpression mitigated fasting-induced organ shrinkage, so YAP opposes the fasting phenotype. In adipose, YAP/TAZ activation cut fat mass while raising leptin, so YAP drives a fat-loss phenotype. These are not the same relationship to fasting and are reported side by side without adjudication.
Graded rows
| # | Modality | System | Tier | Grade | Finding | Source |
|---|---|---|---|---|---|---|
| 7.1 | PF, fasting-refeeding transition (duration not stated in the retrieved record) | Mouse liver | A1 | C | Fasting reduced liver size, hepatocyte size and hepatocyte proliferation; refeeding reversed all three. Fasting or refeeding altered YAP and its downstream target CCND1, DIRECTION NOT STATED. AAV-Yap(5SA) mitigated the fasting-induced liver size reduction and blocked the fasting effect on hepatocyte size and proliferation. Yap shRNA delayed size recovery after refeeding. | Li et al. 2023, Acta Pharm Sin B 13(4):1588-1599, PMID 37139422, DOI 10.1016/j.apsb.2022.12.011 |
| 7.2 | PF, fasting and refeeding | Mouse adipose tissue | A1 | C | YAP/TAZ activity associated with and functionally required for leptin regulation during fasting and refeeding, DIRECTION OF THE FASTING CHANGE NOT STATED. Adipocyte Lats1/Lats2 deletion activated YAP/TAZ, sharply reduced fat mass by converting mature adipocytes into delipidated progenitor-like cells without lipodystrophic metabolic dysfunction, and paradoxically raised circulating leptin. YAP/TAZ-TEAD binds an upstream enhancer of the leptin gene. | Choi et al. 2024, Nat Metab 6(5):847-860, PMID 38811804, DOI 10.1038/s42255-024-01045-4 |
Open questions
- The directional gap in rows 7.1 and 7.2 is the whole state of this node. Until a retrieved source states whether fasting raises or lowers YAP or TAZ, no customer-facing sentence can say which way this node moves under fasting.
- STK3/4, SAV1, MOB1, NF2, the TEAD family and the FAT family are unmeasured under fasting in everything retrieved. The founder's page not marking Hippo "In the recommender" is consistent with what the literature supports.
← 6. Wnt / β-catenin All 41 nodes 8. TGF-β / SMAD →
dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.